-
Mashup Score: 7Targeting T-cell Lipid Metabolism May Improve Cancer Immunotherapy - 3 month(s) ago
Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7Virtual Palliative Care Outcomes Similar to In-Person, Study Finds - 3 month(s) ago
Patients receiving palliative care via telehealth report similar quality-of-life scores compared to those who had in-person care, according to a multicenter clinical trial recently published in JAMA.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7Virtual Palliative Care Outcomes Similar to In-Person, Study Finds - 3 month(s) ago
Patients receiving palliative care via telehealth report similar quality-of-life scores compared to those who had in-person care, according to a multicenter clinical trial recently published in JAMA.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 10Uncovering Regulatory Mechanisms of T-cells in Chronic Inflammation - 3 month(s) ago
Northwestern Medicine scientists have discovered a new underlying mechanisms that controls a specialized group of T-cells, findings that may serve as potential targets for treating inflammatory diseases and cancer, according to a recent study.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13Improving Next-Generation Cancer Treatments - 3 month(s) ago
Northwestern Medicine scientists have developed a more effective method of delivering a cutting-edge cancer treatment, according to findings published in the journal ACS Nano.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13B-Cells Hold Promise for Treating Glioblastoma - 3 month(s) ago
Harnessing the body’s own B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 97New Chief of Division of Hematology and Oncology Named - 3 month(s) ago
Hidayatullah G. Munshi, MD, ‘02, ‘04 GME, has been named chief of Feinberg’s Division of Hematology and Oncology in the Department of Medicine.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 19Molecular Profiling May Improve Meningioma Decisionmaking - 4 month(s) ago
Investigators have demonstrated how molecular profiling of tumors can be used to help predict treatment response and survival in patients with meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Medicine.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 8Combination Treatment Improves Survival in Advanced Prostate Cancer with Genetic Mutations - 4 month(s) ago
A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with genetic mutations compared to either therapy alone or sequentially, according to results from a Northwestern Medicine-led clinical trial.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Abiraterone/prednisone + olaparib improved progression-free survival in patients with advanced #prostatecancer with distinct genetic mutations, per a @ThePCCTC-managed multi-center clinical trial led by Maha Hussain, MD, of @LurieCancer in @CCR_AACR. https://t.co/C2uZQNmFur… https://t.co/RcLhSXruan https://t.co/JyQpW9mRtj
-
Targeting T-cell lipid #metabolism may improve response to cancer #immunotherapy, according to a study from @BinZhang_NU, co-leader of @LurieCancer’s Tumor Environment & Metastasis Program, published in @ImmunityCP: https://t.co/XB8GEOtXA1 via @NUFeinbergMed